These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7952550)
1. Partial inhibition of the early and late asthmatic response by a single dose of salmeterol. Weersink EJ; Aalbers R; Koëter GH; Kauffman HF; De Monchy JG; Postma DS Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1262-7. PubMed ID: 7952550 [TBL] [Abstract][Full Text] [Related]
2. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Pedersen B; Dahl R; Larsen BB; Venge P Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646 [TBL] [Abstract][Full Text] [Related]
3. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209 [TBL] [Abstract][Full Text] [Related]
4. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003 [TBL] [Abstract][Full Text] [Related]
5. Potential masking effects of salmeterol on airway inflammation in asthma. Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027 [TBL] [Abstract][Full Text] [Related]
6. One week treatment with salmeterol does not prevent early and late asthmatic responses and sputum eosinophilia induced by allergen challenge in asthmatics. Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Giannini D; Taccola M; Vagaggini B; Paggiaro PL Pulm Pharmacol Ther; 2004; 17(3):147-53. PubMed ID: 15123224 [TBL] [Abstract][Full Text] [Related]
7. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549 [TBL] [Abstract][Full Text] [Related]
8. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. Kraft M; Wenzel SE; Bettinger CM; Martin RJ Chest; 1997 May; 111(5):1249-54. PubMed ID: 9149578 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550 [TBL] [Abstract][Full Text] [Related]
10. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Gongora HC; Wisniewski AF; Tattersfield AE Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):626-9. PubMed ID: 1679981 [TBL] [Abstract][Full Text] [Related]
11. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma. Yates DH; Worsdell M; Barnes PJ Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023 [TBL] [Abstract][Full Text] [Related]
12. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Wong BJ; Dolovich J; Ramsdale EH; O'Byrne P; Gontovnick L; Denburg JA; Hargreave FE Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1156-60. PubMed ID: 1443864 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of cetirizine on early and late asthmatic response after allergen challenge. de Bruin-Weller MS; Rijssenbeek-Nouwens LH; de Monchy JG J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):231-9. PubMed ID: 8064075 [TBL] [Abstract][Full Text] [Related]
15. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Yates DH; Kharitonov SA; Barnes PJ Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554 [TBL] [Abstract][Full Text] [Related]
17. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma]. Chazan R; Grubek-Jaworska H; Hermanowicz-Salomon J; Droszcz W Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726 [TBL] [Abstract][Full Text] [Related]
18. Diurnal change of bronchial caliber and airway responsiveness in asthmatics during long-term treatment with long-acting beta 2-agonist salmeterol. Dottorini ML; Tantucci C; Peccini F; Grassi V; Sorbini CA Int J Clin Pharmacol Ther; 1996 Oct; 34(10):438-43. PubMed ID: 8897082 [TBL] [Abstract][Full Text] [Related]
19. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness. Strandberg K; Ek A; Palmberg L; Larsson K J Intern Med; 2008 Jul; 264(1):83-94. PubMed ID: 18298484 [TBL] [Abstract][Full Text] [Related]
20. Tolerance to the protective effect of salmeterol on allergen challenge. Giannini D; Carletti A; Dente FL; Bacci E; Di Franco A; Vagaggini B; Paggiaro PL Chest; 1996 Dec; 110(6):1452-7. PubMed ID: 8989060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]